Food and Drug Administration (FDA)

documents

Benchmarking Dissent Processes and Best Practices

letters

POGO Asks President to Withdraw FDA Nominee POGO Urges Senate to Vote Against Nominee to the FDA POGO Letter to Associate Commissioner Warner, FDA, Questioning FDA's Handling of Conflicts of Interest on FDA Advisory Committees POGO and Partners Oppose House Bill that Allows FDA More Secrecy POGO and Groups Support Better Information on Clinical Trials POGO and Partners Oppose FDA Secrecy POGO Letter: FDA Advisors on Yaz and Yasmin Have Industry Ties POGO Letter Urges FDA Not to Weaken Conflict of Interest Standards at Center for Drug Evaluation and Research POGO Letter to FDA Commissioner Hamburg Concerning the Potentially Dangerous Interaction of the Drugs Seroquel and Methodone POGO Asks DHHS Secretary Sebelius to Reinvestigate FDA's Negligent Oversight of Unsafe Medical Devices POGO Letter to FDA Commissioner Margaret Hamburg Regarding Potentially Dangerous Drug Interaction Invovling Seroquel and Methadone POGO's letter to Deputy HHS IG on FDA's CDRH's low standard of medical devices approval The Finances Of FDA Advisory Committee Members: If Information Must Be Withheld, Let It Be Done Openly POGO's letter to Commissioner Hamburg regarding medical devices POGO Letter to FDA's Daniel Schultz MD regarding a policy decision by CDRH to discontinue inspections of nonclinical laboratories POGO Asks FDA Head to Have Deadly Syringe Incident Investigated POGO letter to FDA's Daniel Schultz MD regarding the lack of GLP inspections POGO Follow-up letter to CDRH Director Daniel Schultz POGO Letter to CDRH Director Daniel Schultz regarding a series of questions about the apparent decision not to enforce the GLP regulation

Latest

Hearing Without Listening

analysis | December 16, 2020

Read

Latest

FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns

investigation | December 9, 2020

Read

FDA Whitewashes Warnings About Coronavirus Vaccine Trials

analysis | November 2, 2020
HHS, Inc.: Big Pharma Ties Draw Pandemic Response Concerns

investigation | October 26, 2020
Some FDA Advisors Tapped to Review Coronavirus Vaccines Received Payments from Vaccine Companies

investigation | October 21, 2020
Corrupted: Will Cronyism and Politics Hamper the Vaccine Program?

analysis | August 13, 2020
Stifling Dissent

report | July 31, 2020
Coronavirus Relief Act Gives Drug Makers New Sway Over FDA

investigation | May 5, 2020
Following the (Drug) Money

investigation | May 5, 2020
The Government We Need During the Coronavirus Pandemic

analysis | March 13, 2020